Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/18/15 → 03/20/18 |
Funding
- Novartis Pharmaceuticals Corporation: $6,750.00
A Phase III Randomized, Double-Blind, Placebo-Controlled Study of LEE011 or Placebo in Combination with Tamoxifen and Goserelin or a Non-Steroidal Aromatase Inhibitor (NSAI) and Goserelin for the Treatment of Premenopausal Women with Horm
- Cohen, Jules A (PI)
- Baer, Lea (CoPI)
- Kudelka, Andrzej (CoPI)
Project: Research